1. Home
  2. KEN vs EVO Comparison

KEN vs EVO Comparison

Compare KEN & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kenon Holdings Ltd.

KEN

Kenon Holdings Ltd.

HOLD

Current Price

$65.16

Market Cap

2.7B

Sector

Utilities

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.13

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KEN
EVO
Founded
2014
1993
Country
Singapore
Germany
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
1.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
KEN
EVO
Price
$65.16
$3.13
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
12.1K
269.8K
Earning Date
12-03-2025
11-05-2025
Dividend Yield
7.33%
N/A
EPS Growth
177.70
N/A
EPS
8.96
N/A
Revenue
$803,304,000.00
$887,396,457.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$8.80
P/E Ratio
$7.14
N/A
Revenue Growth
8.15
N/A
52 Week Low
$27.10
$2.84
52 Week High
$66.36
$5.10

Technical Indicators

Market Signals
Indicator
KEN
EVO
Relative Strength Index (RSI) 76.52 51.23
Support Level $60.35 $2.87
Resistance Level $62.68 $3.05
Average True Range (ATR) 1.24 0.09
MACD 0.11 0.02
Stochastic Oscillator 87.76 75.68

Price Performance

Historical Comparison
KEN
EVO

About KEN Kenon Holdings Ltd.

Kenon Holdings Ltd is a holding company that operates dynamic, growth-oriented businesses. The company's operating segments include OPC Power Plants, CPV Group, and ZIM. It generates maximum revenue from the OPC Power Plants segment, which generates and supplies electricity and energy in Israel. CPV Group is a limited partnership owned by OPC, which generates and supplies electricity and energy in the United States. Geographically, the company generates a majority of its revenue from Israel and the rest from the United States.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: